ArticleJournal of Alzheimer's disease reports2023

Pilot Randomized, Double-Blind, Placebo-Controlled Crossover Trial Evaluating the Feasibility of an Intranasal Oxytocin in Improving Social Cognition in Individuals Living with Alzheimer's Disease.

Johannes C Michaelian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.